Region: Global
Category: General In Vitro Diagnostics

Global General In Vitro Diagnostics

(352 reports matching your criteria)
  • Carrier Screening

    ... CAGR of 15.6% over the analysis period 2024-2030. Molecular Screening Test, one of the segments analyzed in the report, is expected to record a 17.4% CAGR and reach US$5.5 Billion by the end of the ... Read More

  • Paper Diagnostics

    ... CAGR of 6.6% over the analysis period 2024-2030. Lateral Flow Assay Kits, one of the segments analyzed in the report, is expected to record a 6.2% CAGR and reach US$6.7 Billion by the end of ... Read More

  • Thyroid Function Tests

    ... at a CAGR of 4.0% over the analysis period 2024-2030. TSH Tests, one of the segments analyzed in the report, is expected to record a 4.0% CAGR and reach US$1.2 Billion by the end of ... Read More

  • Chlamydia Infection Diagnostics and Therapeutics

    ... Billion by 2030, growing at a CAGR of 4.8% over the analysis period 2024-2030. Chlamydia Infection Diagnostics, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$1.6 ... Read More

  • Clinical Risk Grouping Solutions

    ... 2030, growing at a CAGR of 13.8% over the analysis period 2024-2030. Scorecard & Visualization Tools, one of the segments analyzed in the report, is expected to record a 15.1% CAGR and reach US$1.1 Billion ... Read More

  • C-Reactive Protein Testing

    ... at a CAGR of 1.7% over the analysis period 2024-2030. Cardiovascular Diseases, one of the segments analyzed in the report, is expected to record a 2.6% CAGR and reach US$1.0 Billion by the end of ... Read More

  • In Vitro Toxicology Testing

    ... 2030, growing at a CAGR of 8.8% over the analysis period 2024-2030. Cell Culture Technology, one of the segments analyzed in the report, is expected to record a 8.2% CAGR and reach US$11.2 Billion by ... Read More

  • Sepsis Diagnostics

    ... CAGR of 7.5% over the analysis period 2024-2030. Microbiology Technology, one of the segments analyzed in the report, is expected to record a 9.1% CAGR and reach US$749.8 Million by the end of the analysis ... Read More

  • Rabies Diagnostics

    ... CAGR of 5.4% over the analysis period 2024-2030. Fluorescent Antibody Tests (FAT) Method, one of the segments analyzed in the report, is expected to record a 5.2% CAGR and reach US$910.1 Million by the end ... Read More

  • ADME-Toxicology Testing

    ... CAGR of 11.2% over the analysis period 2024-2030. Cell Culture Technology, one of the segments analyzed in the report, is expected to record a 13.2% CAGR and reach US$9.6 Billion by the end of the ... Read More

  • Biosensors

    ... 7.2% over the analysis period 2024-2030. Non-wearable Biosensors, one of the segments analyzed in the report, is expected to record a 6.6% CAGR and reach US$28.3 Billion by the end of the analysis period. Growth ... Read More

  • Helicobacter Pylori Diagnostics

    ... at a CAGR of 4.8% over the analysis period 2024-2030. Invasive Test, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$556.8 Million by the end of ... Read More

  • Bio-MEMS Devices

    ... CAGR of 16.7% over the analysis period 2024-2030. Implantables, one of the segments analyzed in the report, is expected to record a 15.7% CAGR and reach US$18.2 Billion by the end of the analysis period. ... Read More

  • Anatomic Pathology

    ... CAGR of 5.8% over the analysis period 2024-2030. Anatomic Pathology Services, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$36.4 Billion by the end of the ... Read More

  • Bio-MEMS

    ... 16.7% over the analysis period 2024-2030. Microfluidic Chips, one of the segments analyzed in the report, is expected to record a 17.1% CAGR and reach US$27.4 Billion by the end of the analysis period. Growth ... Read More

  • Cardiac Biomarkers

    ... CAGR of 7.3% over the analysis period 2024-2030. Troponins (T & I), one of the segments analyzed in the report, is expected to record a 8.5% CAGR and reach US$11.2 Billion by the end of ... Read More

  • In-Vitro Diagnostics (IVD) Packaging

    ... 2030, growing at a CAGR of 4.5% over the analysis period 2024-2030. Bottles, one of the segments analyzed in the report, is expected to record a 3.3% CAGR and reach US$4.0 Billion by the end ... Read More

  • AI Vision Market by Vision Software (API, SDK), Vision Platform, Behavioral Analysis, Optical Character Recognition, Spatial Analysis, Image Recognition, Heatmap Analysis, Machine Learning, Deep Learning, CNN, Generative AI – Global Forecast to 2029

    ... accelerated growth due to the high adoption of cloud computing, machine learning (ML), and deep learning (DL). Advancements in edge computing boost the demand for real-time analytics in the automotive and manufacturing sectors. However, the ... Read More

  • Tissue Diagnostics: Technologies and Global Markets

    ... recent activities. The report analyzes market dynamics, including drivers, limitations, challenges and opportunities, and discusses current and potential market size. The report will enable companies in the industry to make informed decisions about the production ... Read More

  • Allergy Diagnostics Global Market Report 2025

    ... User: Diagnostics Laboratories; Hospital-based Laboratories; Academic and Research InstitutesCovering: BioMerieux SA; Danaher Corporation; HOB Biotech Group Corp. Ltd.; HYCOR Biomedical; Lincoln Diagnostics Inc. Allergy Diagnostics Global Market Report 2025 from The Business Research Company provides ... Read More

  • Global In Vitro Diagnostics (IVD) Consumables Market Report, History and Forecast 2019-2030

    ... a revised size of US$ 92,633 million by 2030, growing at a CAGR of 4.2% during the forecast period 2024-2030. North American market for In Vitro Diagnostics (IVD) Consumables was valued at $ 26,891 million ... Read More

  • Global Latex Particle for In-Vitro Diagnostics Market Insights, Forecast to 2030

    ... at a Compound Annual Growth Rate (CAGR) of 5.48% during the forecast period. At present, the market concentration of the latex particle for IVD industry is relatively high due to the high technology barrier. Key ... Read More

  • Global Escherichia Coli Testing Market 2024-2028

    ... period. The report on the escherichia coli testing market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an ... Read More

  • 2025 Global: Composite Diagnostic Or Laboratory Reagents, Including Paper Impregnated Or Coated With Diagnostic Or Laboratory Reagents Products-Manufacturing Forecast (2031) report

    ... Diagnostic Or Laboratory Reagents Products-Manufacturing Forecast (2031) report analyzies the market size, projected growth/decline and regional data for the period 2020 through 2031. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our ... Read More

  • IVD Quality Control Market

    ... primarily fueled by the advancements in diagnostic technologies, escalating demand for precise diagnostic testing, rising interest in point-of-care testing, and strict regulatory requirements. Additionally, growing healthcare expenditure and improved access to advanced diagnostic tools in ... Read More

< prev 1 2 3 4 5 6 7 8 9 10

Research Assistance

Live help

Join Alert Me Now!

Sign Up

Find out more on our blog
Cookie Settings